Chlorhexidine gluconate is used to prevent the accumulation of
dental plaque and
gingivitis,
infection of the surgical site, and
ventilator-associated pneumonia in
maxillofacial surgery, but it is not clear whether the metabolites of
chlorhexidine are detectable in the patient's saliva at clinically relevant concentrations. Forty-three patients who had orofacial operations were randomised to use a 0.2%
chlorhexidine gluconate (n=23), or an
octenidine-based,
chlorhexidine-free (n=20), mouthwash once preoperatively and three times daily for five postoperative days. After the first, 8.7 (23.3) mg/L
chlorhexidine (0.7%-2.5% of the total amount used) was measured in saliva. The concentration increased to 15.2 (6.2) mg/L after the second rinse (first postoperative day), and peaked at 29.4 (11.2) mg/L on the fourth postoperative day. It remained detectable for up to 12hours after the last one, but was not detectable in serum or urine at any time. The potentially carcinogenic metabolite
p-chloroaniline was detectable in saliva at higher concentrations in the
chlorhexidine group (0.55mg/L) than the
octenidine group (0.21mg/L), and
p-chloronitrobenzene was detected in both groups in only minimal concentrations (0.001-0.21mg/L).
Chlorhexidine gluconate mouthwashes do increase the concentration of
p-chloroaniline, but a single use seems to be safe. Whether prolonged exposure over many years may have carcinogenic potential is still not clear. Based on the hitherto unknown kinetics of
p-chloroaniline in saliva, the recent recommendation of the Federal Drug Administration (FDA) in the USA to limit the use of a
chlorhexidine gluconate mouthwash to a maximum of six months seems to be justified.